Is Stemtech Corp (OTC-STEK) undervalued or overvalued?

A clear undervalued or overvalued classification is not currently available in the latest data file.

How is the financial health of Stemtech Corp?

The current financial health read for Stemtech Corp (OTC-STEK) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Stemtech Corp's next earnings date?

The next earnings date currently listed for Stemtech Corp (OTC-STEK) is August 19, 2026.

Does Stemtech Corp (OTC-STEK) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for Stemtech Corp (OTC-STEK)?

The current P/E ratio listed for Stemtech Corp (OTC-STEK) is 0.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Stemtech Corp?

The current market capitalization listed for Stemtech Corp is 2.371 K.

What is the enterprise value of Stemtech Corp?

The current enterprise value listed for Stemtech Corp is 3.983 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Stemtech Corp?

The ticker symbol for Stemtech Corp is OTC-STEK, and the stock is listed on OTC Markets.

Where is Stemtech Corp (OTC-STEK) listed?

Stemtech Corp (OTC-STEK) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Stemtech Corp?

The current debt-to-total-capital ratio listed for Stemtech Corp is 111.4%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Stemtech Corp?

The free float listed for Stemtech Corp is 98.1%. Free float helps investors understand how much of the share base is available for public trading.

Stemtech Corp (STEK) Fair Value & Stock Analysis

Q: What is the fair value of Stemtech Corp (OTC-STEK) stock?

A fair value estimate for Stemtech Corp (OTC-STEK) is not currently available in the latest data file.

Q: What is the analyst price target for OTC-STEK stock?

An analyst price target for Stemtech Corp (OTC-STEK) is not currently available in the latest data file.

Stemtech Corp (STEK)

Stemtech Corp is a consumer staples company focused on stem cell nutrition and personal care products. Operating as common stock on the OTC Markets under the ticker STEK, the company develops science-based products intended to support healthy stem cell physiology. Its product range includes the rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, Collect One, and the Cellect One shield hypochlorous acid skin care product. Stemtech distributes its products through independent distributors and serves customers across the Americas, Latin America, and Asia. The company was founded in 2005 and is headquartered in Naples, Florida.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-STEK	—	—	—	—	—	—	Weak	—	—	—	0.0%	August 19, 2026	0.0x	0.0x	0.0x	2.371 K	3.983 M	111.4%	98.1%	-111.8	—	5.2%